Sensorcaine-MPF (Bupivacaine HCl and Epinephrine Injection, USP), 0.5%, 150 mg per 30 mL (5 mg per mL), 30 mL Single Dose Vial (NDC 63323-462-01), packaged as 25 Single Dose Vials per tray (NDC 63323-462-37), Rx only, Fresenius Kabi, Lake Zurich, IL 60047.
Published December 30, 2020 · Recall initiated: December 10, 2020
Summary
FDA records drug Class II recall D-0172-2021, published December 30, 2020 and initiated December 10, 2020. Recalling firm: Fresenius Kabi USA, LLC; Status: Terminated; Reported quantity: 4411 trays; Lot: Batch # 6123760, Exp 02/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug: Low out-of-specification assay results for the epinephrine component.
What to do
Voluntary: Firm initiated · Letter
Get an email if SENSORCAINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- SENSORCAINE
- Manufacturer
- Fresenius Kabi USA, LLC
- Distributor
- Nationwide in the USA
- Lot
- Batch # 6123760, Exp 02/2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASensorcaine (Bupivacaine HCl and Epinephrine Injection, USP) with Epinephrine 1:200,000 (as bitartrate), 0.5%,January 25, 2023
- FDASensorcaine-MPF (Bupivacaine HCl and Epinephrine Injection, USP) with Epinephrine 1:200,000 (as bitartrate),January 25, 2023
- FDASensorcaine (Bupivacaine HCl and Epinephrine Injection, USP) with Epinephrine 1:200,000 (as bitartrate),January 25, 2023
- FDAVasopressin 20 Units added to 0.9% Sodium Chloride 100 mL Rx Only, Single Dose Container, SCA PharmaceuticalsDecember 30, 2020
- FDAHydroxyzine Hydrochloride Oral Solution, USP (Syrup), 10 mg/5 mL, packaged in a) 4 fl oz (118 mL) bottle, NDCDecember 30, 2020
- FDAAuryxia (ferric citrate) tablets, 210 mg, 200-count bottles, Rx only, Manufactured for and distributed by:December 30, 2020
Questions about this recall
Was Sensorcaine-MPF (Bupivacaine HCl and Epinephrine Injection, USP), 0.5%, 150 mg per 30 mL (5 mg per mL), 30 mL Single Dose Vial (NDC 63323-462-01), packaged as 25 Single Dose Vials per tray (NDC 63323-462-37), Rx only, Fresenius Kabi, Lake Zurich, IL 60047. recalled?
Yes. FDA published recall D-0172-2021 on December 30, 2020. Reported hazard: Subpotent Drug: Low out-of-specification assay results for the epinephrine component.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: SENSORCAINE.